Florian Buchkremer

Nephrologist. Views are my own. #FOAMed supporter. #UrinarySediment #ultrasound #nephrology #hyponatremia

[Florian Buchkremer @swissnephro]

1/3 Our paper on classifying #hyponatremia is out 🎉

https://t.co/F1EQ66atOg

Thanks to @ChristCrain @ClinNeuroEndo for generously providing the #CoMedStudy data!

[Renal Fellow Network @RenalFellowNtwk]

Leucine Crystals in the Urine!
By @swissnephro and Alina Stamm
#urinemicroscopy

https://t.co/mgddSV4Jba

[Michelle Rheault @rheault_m]

Division Director life. H/t @NewYorker

[Kate Robson @nephrologista]

Top tips on developing a statistical analysis plan for your trial from @lastwalsh #GlomConHawaii

[Poyan Mehr @poyanmehr]

Unreal. It’s like meeting someone you have virtually raised a kid with for the first time.
There is no better place to celebrate this journey than in paradise #GlomConHawaii
🤙

[Leonardo V. Riella @LVRiella]

With tremendous joy, I share that our patient who received a gene-edited pig kidney transplant was discharged home today after removal of his dialysis access. We hope that this is a first step that will bring hope to many patients waiting for a kidney transplant #xenotransplant

[David Juurlink @DavidJuurlink]

In short, losartan is the codeine of ARBs:

- it doesn't do much on its own
- any effect is due to a metabolite
- metabolite formation is genetically determined

The result? Unpredictability and potential interactions with CYP inhibitors & inducers.

And who needs that?

/ end

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Transition from an eGFR-based to a risk-based approach to CKD care from @goKDIGO #Nephpearls

📌 Practice Point 2.2.1: A 5-year kidney failure risk of 3%–5% can be used to determine need for nephrology referral in addition to criteria based on eGFR or urine ACR, and other clinical considerations

📌 Practice Point 2.2.2: A 2-year kidney failure risk of >10% can be used to determine the timing of multidisciplinary care in addition to eGFR-based criteria and other clinical considerations

⚠️Practice Point 2.2.4: Note that risk prediction equations developed for use in people with CKD G3-G5, may not be valid for use in those with CKD G1-G2

👉 https://t.co/qLQX2YcI8e

[Jasmine Sethi @JasmineNephro]

🫘🎯Let’s look at the must know Nephrology updates in last year

https://t.co/rtdfwZSAfn

@NephJC

[Tom Nolin @Tom_Nolin]

Long-awaited update of @US_FDA Guidance related to Assessment of PK and Drug Dosing in people w/ Impaired Kidney Fxn now issued! Important info RE: determining kidney fxn, assessing PK of nonrenally cleared drugs, and evaluating PK and dosing during CRRT. https://t.co/7QWUt8S24x

[Florian Buchkremer @swissnephro]

@SunOfLife3 Both structures looks like fiber artefacts to me.

[Mohamed E. Elrggal @M_Elraggal]

Management of Hypertension in Diabetic Kidney Disease with @edgarvlermamd @DoctorGates @AnnaGaddy @HecmagsMD @JCM_MDPI
https://t.co/VXA0PRABw2

[Matthew Sparks, MD @Nephro_Sparks]

Happy #NephMadness day

https://t.co/WpHiJ7lOon

[Dr. Glaucomflecken @DGlaucomflecken]

Happy Super Bowl Sunday!

[Swapnil Hiremath @hswapnil.medsky.social @hswapnil]

More on #Flozination associated with 25-30% lower risk of kidney stones

From Boston, propensity score matched

https://t.co/SO5K8xtg2K in @JAMAInternalMed

cc @weddellite - should we prescribe flozins instead of thiazides😏?

[Roger Rodby @NephRodby]

@thisis_drgsp @NephJC @hswapnil What new isn't $$$? expensivuzmab, spar-spend-an, broke-desonide, avaco-pain, oh-no-utuzumab, tenapa-more...

[ASN Kidney360 @ASNKidney360]

Identification of casts by urinary sediment microscopy is a valuable diagnostic tool for kidney disease. This Podcast discusses a study that found urinary vacuolar casts are strongly linked to advanced glomerulopathies with severe proteinuria https://t.co/v4vJawEvMO

[Michelle Rheault @rheault_m]

You know how you get to the end of a book and you’re sad because you love all the characters and don’t want them to go away?

That’s how I feel about the current state of Twitter.

[Matthew Sparks, MD @Nephro_Sparks]

🔥 cover for @AJKDonline this month

Almost #NephMadness time

[Roger Rodby @NephRodby]

Yesterday, my friend, colleague and fellow @BookBurton podcaster Anna Gaddy (@AnnaGaddy) became an altruistic kidney donor! She is home already and her donated kidney is working and just saved someone's life. Go Anna! #WalkTheWalk

[Daniel G. Fuster @Dan_Fuster]

@weddellite @CJASN @NEJM @NephJC This is a very selective, bias view at the study, neglecting 95 % of NOSTONE data. What about no difference for the primary end point among groups despite a recurrence rate of 59 % in the placebo arm over 3 years ?